Investor Presentation Q1-Q3 2020 slide image

Investor Presentation Q1-Q3 2020

Investor presentation First nine months of 2020 SECURE A LEADING POSITION BY LEVERAGING FULL PORTFOLIO AND EXPANDING INTO ADJACENT AREAS 1. Haemophilia 2. Growth hormone disorders 3. Biopharm innovation 61 62 64 Biopharm CHRIS BOMBARDIER Chris has haemophilia B US
View entire presentation